Toxicity and carcinogenicity of chromium compounds in humans

Critical Reviews in Toxicology

Volumn 36, Issue 2, 2006, Pages 155-163

  Costa, Max ^a   Klein, Catherine B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis Risk Assessment; Chromium; Drinking Water; Skin Cancer; Uptake

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CHROMIUM DERIVATIVE; CIGARETTE SMOKE;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICAL CARCINOGENESIS; CHINA; DIGESTIVE SYSTEM CANCER; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EXPOSURE; HUMAN; INGESTION; LUNG CANCER; MEDICAL RECORD; NEUROTOXICITY; NONHUMAN; OCCUPATION; OCCUPATIONAL CANCER; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PROSTATE CANCER; RESPIRATORY TRACT CANCER; REVIEW; RISK ASSESSMENT; SKIN CANCER; SMOKING; TOXICITY TESTING; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHROMIUM COMPOUNDS; HUMANS; NEOPLASMS; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 33644990108     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440500534032     Document Type: Review

References (67)

1. Aaseth, J., Alexander, J., and Norseth, T. (1982). Uptake of 51Cr-chromate by human erythrocytes-a role of glutathione. Acta Pharmacol Toxicol. (Copenh.) 50(4):310-315.
2. Alexander, J., and Aaseth, J. (1995). Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier. Analyst 120(3):931-933.
3. Attenburrow, M.J., Mitter, P.R., Whale, R., Terao, T., and Cowen, P.J. (2002). Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology 159(4):432-436.
4. Bagchi, D., Vuchetich, P.J., Bagchi, M., Hassoun, E.A., Tran, M.X., Tang, L., and Stohs, S.J. (1997). Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic. Biol. Med. 22(3):471-478.
5. Bagchi, D., Bagchi, M., and Stohs, S.J. (2001). Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol. Cell Biochem. 222(1-2):149-158.
6. Biedermann, K.A., and Landolph, J.R. (1987). Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 47(14):3815-3823.
7. Biedermann, K.A., and Landolph, J.R. (1990). Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res. 50(24):7835-7842.
8. Borneff, J., Engelhardt, K., Griemm W., Kuntem H., and Reichert, J. (1968). Carcinogens in water and soil. XXII. Experiment with 3,4-benzopyrene and potassium chromate in mice drink. Arch. Hyg. Bakteriol. 152(1):45-53.
9. Bridgewater, L.C., Manning, F.C., and Patierno, S.R. (1994). Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand crosslinking. Carcinogenesis 15(11):2421-2427.
10. Bridgewater, L.C., Manning, F.C., and Patierno, S.R. (1998). Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinogen. 23(4):201-206.
11. Capellmann, M., Mikalsen, A., Hindrum, M., and Alexander, J. (1995). Influence of reducing compounds on the formation of DNA-protein cross-links in HL-60 cells induced by hexavalent chromium. Carcinogenesis 16(5):1135-1139.
12. Chen, J., and Thilly, W. G. (1994). Use of denaturing-gradient gel electrophoresis to study chromium-induced point mutations in human cells. Environ. Health Perspect. 102(Suppl 3):227-229.
13. Chuang, S.M., Liou, G.Y., and Yang, J.L. (2000). Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21(8):1491-1500.
14. Cohen, M.D., Kargacin, B., Klein, C.B., and Costa, M. (1993). Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 23(3):255-281.
15. Costa, M. (1997). Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit. Rev. Toxicol. 27(5):431-442.
16. Costa, M. (2003). Potential hazards of hexavalent chromate in our drinking water. Toxicol. Appl. Pharmacol. 188(1):1-5.
17. Costa, M., Zhitkovich, A., Harris, M., Paustenbauch, D., and Gargas, M. (1997). DNA-protein cross-links produced by various chemicals in cultured human lymphoma cells. J. Toxicol. Environ. Health 50(5):433-449.
18. Costa, M., Salnikow, K., Sutherland, J.E., Broday, L., Peng, W., Zhang, Q., and Kluz, T. (2002). The role of oxidative stress in nickel and chromate genotoxicity. Mol. Cell. Biochem. 234-235(1-2):265-275.
19. Cupo, D.Y., and Wetterhahn, K.E. (1985). Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes. Proc. Natl. Acad. Sci. USA 82(20):6755-6759.
20. Davidson, T.L., Kluz, T., Burns, F.J., Rossman, T.G., Zhang, Q., Uddin, A., Nadas, A., and Costa, M. (2004). Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol. Appl. Pharmacol. 196(3):431-437.
21. De Flora, S. (2000). Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 21(4):533-541.
22. De Flora, S., Camoirano, A., Bagnasco, M., Bennicelli, C., Corbett, G.E., and Kerger, B.D. (1997). Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 18(3):531-537.
23. Feng, Z., Hu, W., Rom, W.N., Costa, M., and Tang, M.S. (2003). Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells. Carcinogenesis 24(4):771-778.
24. Gibb, H.J., Lees, P.S.J., Pinsky, P.F., and Rooney, B. (2000). Lung cancer among workers in chromium chemical production. Am. J. Ind. Med. 38(2):115-126.
25. Grimsrud, T.K., Berge, S.R., Martinsen, J.I., and Andersen, A. (2003). Lung cancer incidence among Norwegian nickel-refinery workers 1953-2000. J. Environ. Monit. 5(2):190-197.
26. Hartwig, A., and Beyersmann, D. (1989). Comutagenicity and inhibition of DNA repair by metal ions in mammalian cells. Biol. Trace Elem. Res. 21:359-365.
27. Hu, W., Feng, Z., and Tang, M.S. (2004). Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydro benzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair. Biochemistry 43(44):14282-14289.
28. IARC. (1980). Chromium and chromium compounds. IARC Monogr. Eval. Carcinogen. Risk Chem. Hum. 23:205-323.
29. Kerger, B.D., Paustenbach, D.J., Corbett, G.E., and Finley, B.L (1996). Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol. Appl. Pharmacol. 141(1):145-158.
30. Kerger, B.D., Finley, B.L., Corbett, G.E., Dodge, D.G., and Paustenbach, D.J. (1997). Ingestion of chromium(VI) in drinking water by human volunteers: Absorption, distribution, and excretion of single and repeated doses. J. Toxicol. Environ. Health 50(1):67-95.
31. Kuschner, M., and Laskin, S. (1971). Experimental models in environmental carcinogenesis. Am. J. Pathol. 64(1):183-196.
32. Kuykendall, J.R., Kerger, B.D., Jarvi, E.J., Corbett, G.E., and Paustenbach, D.J. (1996). Measurement of DNA-protein cross-links in human leukocytes following acute ingestion of chromium in drinking water. Carcinogenesis 17(9):1971-1977.
33. Långard, S. (1990). One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17(2):189-215.
34. Manning, F.C., and Patierno S.R. (1996). Apoptosis: inhibitor or instigator of carcinogenesis? Cancer Invest. 14(5):455-465.
35. Menvielle, G., Luce, D., Fevotte, J., Bugel, I., Salomon, C., Goldberg, P., Billon-Galland, M.A., and Goldberg, M. (2003). Occupational exposures and lung cancer in New Caledonia. Occup. Environ. Med. 60(8):584-589.
36. Mertz, W. (1998). Chromium research from a distance: from 1959 to 1980. J. Am. Coll. Nutr. 17(6):544-547.
37. Park, R.M., Bena, J.F., Stayner, L.T., Smith, R.J., Gibb, H.J., and Lees, P.S. (2004). Hexavalent chromium and lung cancer in the chromate industry: A quantitative risk assessment. Risk Anal. 24(5):1099-1108.
38. Patierno, S.R., Banh, D., and Landolph, J.R. (1988). Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48(18):5280-5288.
39. Paustenbach, D.J., Hays, S.M., Brien, B.A., Dodge, D.G., and Kerger, B. (1996). Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking water. J. Toxicol. Environ. Health 49(5):453-461.
40. Paustenbach, D.J., Finley, B.L., Mowat, F.S., and Kerger, B.D. (2003). Human health risk and exposure assessment of chromium(VI) in tap water. J. Toxicol. Environ. Health A 66(14):1295-1339.
41. Petrilli, F.L., and De Flora, S. (1988). Metabolic reduction of chromium as a threshold mechanism limiting its in vivo activity. Sci. Total Environ. 71(3):357-364.
42. Proctor, D.M., Otani, J.M., Finley, B.L., Paustenbach, D.J., Bland, J.A., Speizer, N., and Sargent, E.V. (2002). Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review. J. Toxicol. Environ. Health A 65(10):701-746.
43. Rhodes, M.C., Hebert, C.D., Herbert, R.A., Morinello, E.J., Roycroft, J.H., Travalos, G.S., and Abdo, K.M. (2005). Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium piccolinate monohydrate. Food Chem. Toxicol. 43:21-29.
44. Salnikow, K., Zhitkovich, A., and Costa, M. (1992). Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis 13(12):2341-2346.
45. Shi, X.G., Sun, X.L., Gannett, P.M., and Dalal, N.S. (1992). Deferoxamine inhibition of Cr(V)-mediated radical generation and deoxyguanine hydroxylation: ESR and HPLC evidence. Arch. Biochem. Biophys. 293(2):281-286.
46. Shi, X., Mao, Y., Knapton, A. D., Ding, M., Rojanasakul, Y., Gannett, P. M., Dalal, N., and Liu, K. (1994). Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis 15(11):2475-2478.
47. Slesinski, R.S., Clarke, J.J., San, R.H.C., and Gudi, R. (2005). Lack of mutagenicity of chromium piccolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res. 585(1-2):86-95.
48. Sugiyama, M. (1992). Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radical Biol. Med. 12(5):397-407.
49. 4 in synchronous and asynchronous cultured mammalian cells. Mol. Pharmacol. 29(6):606-613.
50. Suzuki, Y. (1988). Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid. Arch. Toxicol. 62(2-3):116-122.
51. Travacio, M., Polo, J.M., and Llesuy, S. (2000). Chromium(VI) induces oxidative stress in the mouse brain. Toxicology 150(1-3):137-146.
52. Travacio, M., Polo, J.M., and S. Llesuy, S. (2001). Chromium(VI) induces oxidative stress in the mouse brain. Toxicology 162(2):139-148.
53. Ueno, S., Kashimoto, T., Susa, N., Furukawa, Y., Ishii, M., Yokoi, K., Yasuno, M., Sasaki, Y.F., Ueda, J., Nishimura, Y., and Sugiyama, M. (2001). Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol. Appl. Pharmacol. 170(1):56-62.
54. U.S. Environmental Protection Agency. (1992). Chromium Compounds. http://www.epa.gov/ttn/atw/hlthef/chromium.html
55. U.S. Occupational Safety and Health Administration. 2000. 29CFR1910.1000, Table Z-2.
56. Vincent, J.B. (2004). Recent developments in the biochemistry of chromium(III). Biol. Trace Elem. Res. 99(1-3):1-16.
57. Voitkun, V., Zhitkovich, A., and Costa, M. (1994). Complexing of amino acids to DNA by chromate in intact cells. Environ. Health Perspect. 102(Suppl. 3):251-255.
58. Voitkun, V., Zhitkovich, A., and Costa, M. (1998). Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26(8):2024-2030.
59. Wesseling, C., Pukkala, E., Neuvonen, K., Kauppinen, T., Boffetta, P., and Partanen. T. (2002). Cancer of the brain and nervous system and occupational exposures in Finnish women. J. Occup. Environ. Med. 44(7):663-668.
60. Wetterhahn, K.E., and Hamilton, J.W. (1989). Molecular basis of hexavalent chromium carcinogenicity: Effect on gene expression. Sci. Total Environ. 86(1-2):113-129.
61. Zhang, J.D., and Li, X.L. (1987). Chromium pollution of soil and water in Jinzhou. Zhonghua Yu Fang Yi Xue Za Zhi 21(5):262-264.
62. Zhang, J.D., and Li, S. (1997). Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J. Occup. Environ. Med. 39(4):315-319.
63. Zhang, Q., Kluz, T., Salnikow, K., and Costa, M. (2002). Comparison of the cytotoxicity, cellular uptake, and DNA-protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three different individuals. Biol. Trace Elem. Res. 86(1):11-22.
64. Zhitkovich, A. (2005). Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol. 18(1):3-11.
65. Zhitkovich, A., Voitkun, V., and Costa, M. (1995). Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 16(4):907-913.
66. Zhitkovich, A., Voitkun, V., and Costa, M. (1996). Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: Importance of trivalent chromium and the phosphate group. Biochemistry 35(22):7275-7282.
67. Zhitkovich, A., Song, Y., Quievryn, G., and Voitkun, V. (2001). Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40(2):549-560.